The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mrs. Shanta Somani
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mrs. Shanta Somani, a member of the promoter group of Chemo Pharma Laboratories Limited (along with PAC Citric India Limited), has disclosed a sale of 48,781 equity shares under SEBI SAST Regulation 29(2). This represents her entire 3.25% stake in the company, reducing her post-transaction holding to zero. The target company has 15,00,000 equity shares of Rs. 10 each as its total share capital. The date of sale is not explicitly mentioned in the document, but the disclosure was made on 18 July 2025. This is effectively a complete exit by one of the promoters.
This signals a promoter completely exiting Chemo Pharma Laboratories, which may raise governance or control questions among retail investors. Such a full exit by a promoter could negatively impact sentiment and trigger closer scrutiny of remaining promoter holdings.